SCHEMBL6952509

SCHEMBL6952509

Cc1ccc(S(=O)(=O)S)cc1CC1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
CNR2 P34972 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PARG Q86W56 1/20 0.32
SCN9A Q15858 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RET P07949 1/20 0.32
HTT P42858 1/20 0.32
CYP2C9 P11712 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6961685 0.92 ALDH1A1 (0.39) ALDH1A1CNR2TDP1MEN1KMT2A
SCHEMBL6952517 0.81 ALDH1A1 (0.35) ALDH1A1CNR2MCOLN3LMNATDP1
SCHEMBL7846676 0.79 PIK3CD (0.35) ALDH1A1MCOLN3LMNASCN9AMAPT
SCHEMBL7735410 0.78 ALDH1A1 (0.40) ALDH1A1CNR2MCOLN3LMNATDP1
SCHEMBL6961692 0.75 ALDH1A1 (0.38) ALDH1A1CNR2TDP1MEN1KMT2A
SCHEMBL20504425 0.75 NR1H2 (0.36) SCN9AHTTCA1CA2CA7
SCHEMBL31406419 0.74 ALDH1A1 (0.53) ALDH1A1LMNATDP1MEN1KMT2A
SCHEMBL7363379 0.74 SMN1; SMN2 (0.41) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL6604576 0.73 TAAR1 (0.42) ALDH1A1LMNATDP1MEN1KMT2A
SCHEMBL9239762 0.73 S1PR3 (0.39) ALDH1A1CNR2TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
US-5504104-A TREATING INFECTIONS OR DISEASES CAUSED BY RETROVIRUSES, SUCH AS HIV AND AIDS WARNER-LAMBERT COMPANY (US) 1996-04-02 US disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed